Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study

Ceftazidime-Avibactam Combination Therapy versus Monotherapy for the Treatment Carbapenem-Resistant Gram-Negative Bacterial Infections: A Retrospective Observational Study

Keyang Li,1,* Debao Li,2,* Hongliang Dong,1 Dongmei Ren,2 Dandan Gong,1 Shubo Wang,1 Yang Li,1 Yuanyuan Wu,1 Jikang Yang,3 Wenjuan Yan,4 Yi Li4 1Department of Clinical Pharmacy, Jiaozuo People’s Hospital, Jiaozuo, Henan, People’s Republic of China; 2Department of Clinical Laboratory,...

Full description

Bibliographic Details
Main Authors: Li K, Li D, Dong H, Ren D, Gong D, Wang S, Li Y, Wu Y, Yang J, Yan W
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:Infection and Drug Resistance
Subjects:
ceftazidime-avibactam
carbapenem-resistant gram-negative bacteria
combination therapy
k. pneumoniae carbapenemase
Online Access:https://www.dovepress.com/ceftazidime-avibactam-combination-therapy-versus-monotherapy-for-the-t-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/ceftazidime-avibactam-combination-therapy-versus-monotherapy-for-the-t-peer-reviewed-fulltext-article-IDR

Similar Items